Belle Mead, NJ, United States of America

Shengjian Li


Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 110(Granted Patents)


Company Filing History:


Years Active: 2002-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Shengjian Li

Introduction

Shengjian Li is a prominent inventor based in Belle Mead, NJ (US), known for his significant contributions to the field of medicinal chemistry. With a total of 8 patents to his name, he has made remarkable strides in developing novel compounds that target various kinase interactions.

Latest Patents

Among his latest patents, one notable invention is focused on substituted pyrazole kinase inhibitors. This invention is directed to novel substituted pyrazole compounds of Formula (I) or a form or composition thereof, aimed at inhibiting ATP-protein kinase interactions. Another significant patent involves 3-benzoimidazolyl-pyrazolopyridines, which are useful in treating kinase disorders. This invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I) and their pharmaceutically acceptable forms, emphasizing their synthesis and use as inhibitors of serine-threonine protein kinases and tyrosine protein kinases.

Career Highlights

Shengjian Li has had a distinguished career, working with leading pharmaceutical companies such as Janssen Pharmaceutica NV and Schering Corporation. His work in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Shengjian Li has collaborated with notable professionals in the field, including George Chiu and Peter J. Connolly. These collaborations have further enhanced his research and development efforts.

Conclusion

Shengjian Li's innovative work in the field of kinase inhibitors showcases his dedication to advancing medicinal chemistry. His patents reflect a commitment to developing effective treatments for kinase-related disorders, making him a valuable contributor to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…